Has the Coalition invested an average of $5 billion per year more than Labor into Medicare?
Articles on Medicare
Displaying 221 - 240 of 303 articles
Labor’s shadow health minister Catherine King, said that the government has “cut bulk-billing payments for pathology and diagnostic imaging to make patients pay more”. Is that right?
On the back of Labor’s election launch on Sunday, the party waged a Medicare scare campaign that has reverberated through the whole week.
Health is always a key factor in deciding which way to vote. So what have the major parties promised in health? And what could these changes mean for consumers?
The government needs not just to hose down the Medicare scare but to drag the debate back onto economic ground.
The greater threats to our national public health system lie in the increasing role of consumer co-payments and the power of vested interests that stifle policy innovation in health.
Labor wants the government to guarantee it won’t fully privatise the new Australian Schools Vaccination Register.
When a system is as complex as that of Medicare’s, it is going to be extremely expensive to rebuild and it is not possible to simply “retrofit” an off-the-shelf product from another company.
The posters are going out under Malcolm Turnbull’s signature “I guarantee Medicare stays”. The government is clearly alarmed that Bill Shorten’s Medicare scare campaign could take hold. But what, in the…
Bill Shorten has pledged Labor would reverse the government’s cuts to pathology and give a modest tax break to small businesses to get people back into the workforce.
Pathology Australia promptly abandoned its Don’t Kill Bulk Bill campaign against cuts to bulk-billing incentives after doing a deal with the federal government.
Recent reports have signalled another potential Medicare cost blowout due to the billing practices of GPs providing care after hours. Is it true and is there a problem with these services?
The AMA has campaigned heavily on the Medicare rebate freeze, pointing out its potential impact on patient access if out-of-pocket costs were to increase.
The Conversation’s experts respond to the first Turnbull-Shorten debate with an eye across key policy areas and the leaders’ performances.
Labor will lift the rebate freeze from 2017, while under the Coalition, GPs will be paid the same amount for delivering health services in 2020 as they were in 2014. So what does this mean for patients?
Living with a chronic disease is hard work. Today the federal government announced its intention to “revolutionise” the way chronic diseases and complex conditions are cared for.
Health-care costs are rising, driven by expensive developments in treatments, more demanding populations and rising national wealth. We need to change the financing system to meet this challenge.
The pathology sector in Australia is no longer a cottage industry. It is dominated by a handful of billion-dollar enterprises that analyse blood, tissue and other samples.
Industry consolidation and technological advances have completely reshaped the pathology industry over recent decades. But the way governments pay for pathology services hasn’t kept up.
Republican presidential candidate John Kasich likes to tout his record as governor of Ohio. Is it a case of oversell?
Top contributors
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Professorial Fellow, University of Canberra
-
Jim Gillespie is a Friend of The Conversation.
Associate Professor in Health Policy, Leeder Centre for Health Policy, Economics and Data & Sydney School of Public Health, University of Sydney
-
Program Director, Health and Aged Care, Grattan Institute
-
Adjunct Associate Professor, Menzies Centre for Health Policy and Economics, University of Sydney
-
Associate Professor of Public Health, The Ohio State University
-
Professor of Health Economics, The University of Melbourne
-
Health economist, University of Sydney
-
Professor of Health Economics and Director, Centre for Health Economics Research and Evaluation, University of Technology Sydney
-
Professor of Gerontology, UMass Boston
-
Reader in Health Economics, Centre for Health Economics, University of York
-
Professor of Health Economics and Director, Centre for Health Economics, Monash Business School, Monash University
-
Professor, Public Service Research, UNSW
-
Senior Research Fellow and Lecturer of Gerontology, UMass Boston
-
Associate Professor in Health Economics, Curtin University